Literature DB >> 24486053

Meta'omic analytic techniques for studying the intestinal microbiome.

Xochitl C Morgan1, Curtis Huttenhower2.   

Abstract

Nucleotide sequencing has become increasingly common and affordable, and is now a vital tool for studies of the human microbiome. Comprehensive microbial community surveys such as MetaHit and the Human Microbiome Project have described the composition and molecular functional profile of the healthy (normal) intestinal microbiome. This knowledge will increase our ability to analyze host and microbial DNA (genome) and RNA (transcriptome) sequences. Bioinformatic and statistical tools then can be used to identify dysbioses that might cause disease, and potential treatments. Analyses that identify perturbations in specific molecules can leverage thousands of culture-based isolate genomes to contextualize culture-independent sequences, or may integrate sequence data with whole-community functional assays such as metaproteomic or metabolomic analyses. We review the state of available systems-level models for studies of the intestinal microbiome, along with analytic techniques and tools that can be used to determine its functional capabilities in healthy and unhealthy individuals.
Copyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Metagenomics; Metatranscriptomics; Microbiome; Tools

Mesh:

Substances:

Year:  2014        PMID: 24486053     DOI: 10.1053/j.gastro.2014.01.049

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  55 in total

Review 1.  The gut microbiome in health and in disease.

Authors:  Andrew B Shreiner; John Y Kao; Vincent B Young
Journal:  Curr Opin Gastroenterol       Date:  2015-01       Impact factor: 3.287

Review 2.  Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation.

Authors:  Tessa M Andermann; Andrew Rezvani; Ami S Bhatt
Journal:  Curr Hematol Malig Rep       Date:  2016-02       Impact factor: 3.952

Review 3.  Microbiome-intestine cross talk during acute graft-versus-host disease.

Authors:  Hind Rafei; Robert R Jenq
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

Review 4.  Use of the Microbiome in the Practice of Epidemiology: A Primer on -Omic Technologies.

Authors:  Betsy Foxman; Emily T Martin
Journal:  Am J Epidemiol       Date:  2015-05-29       Impact factor: 4.897

Review 5.  The dormant blood microbiome in chronic, inflammatory diseases.

Authors:  Marnie Potgieter; Janette Bester; Douglas B Kell; Etheresia Pretorius
Journal:  FEMS Microbiol Rev       Date:  2015-05-03       Impact factor: 16.408

6.  Introduction to the special focus issue on the impact of diet on gut microbiota composition and function and future opportunities for nutritional modulation of the gut microbiome to improve human health.

Authors:  Sharon M Donovan
Journal:  Gut Microbes       Date:  2017-02-28

Review 7.  Gastrointestinal surgery and the gut microbiome: a systematic literature review.

Authors:  Suzie Ferrie; Amy Webster; Betty Wu; Charis Tan; Sharon Carey
Journal:  Eur J Clin Nutr       Date:  2020-07-13       Impact factor: 4.016

8.  Methods in microbiome research.

Authors:  Namrata Iyer
Journal:  Lab Anim (NY)       Date:  2016-08-23       Impact factor: 12.625

9.  Mucosa-associated microbiota dysbiosis in colitis associated cancer.

Authors:  Mathias L Richard; Giuseppina Liguori; Bruno Lamas; Giovanni Brandi; Gregory da Costa; Thomas W Hoffmann; Massimo Pierluigi Di Simone; Carlo Calabrese; Gilberto Poggioli; Philippe Langella; Massimo Campieri; Harry Sokol
Journal:  Gut Microbes       Date:  2017-10-12

10.  Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.

Authors:  Giuseppina Liguori; Bruno Lamas; Mathias L Richard; Giovanni Brandi; Gregory da Costa; Thomas W Hoffmann; Massimo Pierluigi Di Simone; Carlo Calabrese; Gilberto Poggioli; Philippe Langella; Massimo Campieri; Harry Sokol
Journal:  J Crohns Colitis       Date:  2015-11-15       Impact factor: 9.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.